Article

Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus

Carşamba Government Hospital, Carşamba, Samsun, Turkey.
Lupus (Impact Factor: 2.48). 12/2009; 19(3):255-61. DOI: 10.1177/0961203309351540
Source: PubMed

ABSTRACT Neurological involvement is a well-documented issue in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, little is known about the involvement of the autonomic nervous system. This study was conducted to investigate autonomic nervous system dysfunction in patients with RA and SLE. Twenty-six RA patients, 38 SLE patients and 40 healthy controls were recruited from our in- and out-patient departments. Heart rate variability (HRV) parameters (the power of the high- [HF] and low-frequency [LF] band of haemodynamic time series, the ratio between low- and high-frequency components [LF/HF ratio], the power spectral density), baroreflex sensitivity (BRS) and beat-to-beat blood pressures were assessed by a novel non-invasive haemodynamic monitoring tool (Task Force Monitor [TFM], CNSystems Medizintechnik GmbH, Graz, Austria). Autonomic nervous system dysfunction was determined according to classical Ewing autonomic test battery. Furthermore, we implemented a secondary autonomic test score by modifying the Ewing test battery with additional criteria. Both the classical and modified Ewing test batteries have revealed that the frequencies of autonomic neuropathy were significantly higher in patient groups compared with controls (p < 0.001). Evaluation by TFM revealed that deterioration of sophisticated autonomic parameters (such as HRV and BRS) were more pronounced in the patient groups compared with controls. There was a significant association between BRS and Ewing test scores and abnormal BRS results were more frequent in patients with autonomic dysfunction according to Ewing test batteries. No relation was found between autonomic neuropathy and disease duration, disease activity and autoantibody positivity. Consequently, we believe that further large-scale studies investigating cardiovascular autonomic neuropathy in rheumatic diseases should be carried out to verify our findings and manifest clinical consequences beyond these results.

Download full-text

Full-text

Available from: Ibrahim Basarici, Jul 01, 2015
0 Followers
 · 
297 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: An implantable cuff electrode technique for collision block of pudendal nerve motor activity has been developed and tested through acute and chronic animal studies. The necessary quasitrapezoidal stimulus parameters for acute and chronic collision block generation have been characterized and are discussed. An asymmetric two-electrode cuff design effectively produces the trains of antidromically propagated action potentials needed to implement a collision block of motor signals to the external periurethral sphincter.< >
    Engineering in Medicine and Biology Society, 1988. Proceedings of the Annual International Conference of the IEEE; 12/1988
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents a power grid analyzer based on a random walk technique. A linear-time algorithm is first demonstrated for DC analysis, and is then extended to perform transient analysis. The method has the desirable property of localizing computation, so that it shows massive benefits over conventional methods when only a small part of the grid is to be analyzed (for example, when the effects of small changes to the grid are to be examined). Even for the full analysis of the grid, experimental results show tat the method is faster than existing approaches and has an acceptable error margin. This method has been applied to test circuits of up to 2.3M nodes. For example, for a circuit with 70K nodes, the solution time for a single node was 0.42 sec and the complete solution was obtained in 17.6 sec.
    Proceedings of the 40th Design Automation Conference, DAC 2003, Anaheim, CA, USA, June 2-6, 2003; 01/2003
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Biological therapeutics targeting TNF, IL-1 and IL-6 are widely used for treatment of rheumatoid arthritis, inflammatory bowel disease and a growing list of other syndromes, often with remarkable success. Now advances in neuroscience have collided with this therapeutic approach, perhaps rendering possible the development of nerve stimulators to inhibit cytokines. Action potentials transmitted in the vagus nerve culminate in the release of acetylcholine that blocks cytokine production by cells expressing acetylcholine receptors. The molecular mechanism of this cholinergic anti-inflammatory pathway is attributable to signal transduction by the nicotinic alpha 7 acetylcholine receptor subunit, a regulator of the intracellular signals that control cytokine transcription and translation. Favourable preclinical data support the possibility that nerve stimulators may be added to the future therapeutic armamentarium, possibly replacing some drugs to inhibit cytokines.
    Journal of Internal Medicine 01/2011; 269(1):45-53. DOI:10.1111/j.1365-2796.2010.02321.x · 5.79 Impact Factor